4
Changes in Ownership
Indaptus Therapeutics, Inc. Filed Acc 0001493152-22-033241
CEO and Director bought 10,000 shares at an average $1.89 ($18,945)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Meckler Jeffrey A CEO and Director | 2022-11-18 | Purchase | +400 | $1.76 | $705 | 65,774 | D |
| Meckler Jeffrey A CEO and Director | 2022-11-21 | Purchase | +9,600 | $1.90 | $18,240 | 75,374 | D |
| Open-market purchases · 10,000 sh · avg $1.89 · $18,945 | |||||||
Loading xslF345X03/ownership.xml…